市场调查报告书
商品编码
1439238
神经监测系统 - 全球市场考量、竞争格局、市场预测 (2030)Nerve Monitoring System - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
全球神经监测系统市场规模预计到2023年将达到12.8亿美元,到2030年将达到16.3亿美元,2024-2030年预测期间复合年增长率为4.17%。对神经监测系统的需求主要是由于患有神经相关疾病的患者数量不断增加、这些手术的医疗报销容易获得、对先进产品的需求不断增加、市场上设备製造商的强势存在等推动的。到过。
神经监测系统的市场动态
影响神经监测系统市场成长的主要因素之一是全球手术量负担的增加。
根据 OECD 的数据,2020 年英国进行了约 9,451 例冠状动脉绕道手术。同年,德国大约进行了 38,859 例冠状动脉绕道手术。据同一消息来源称,2020 年瑞士进行了 26,355 例腔内冠状动脉成形术。同年,西班牙进行了 53,993 例腔内冠状动脉成形术。
与血管摄影和血管内干预相关的神经损伤很少见,通常是短暂的,但可能导致严重的功能性损伤,并且在很大程度上是可以避免的。四分之三接受冠状动脉绕道手术-乳内动脉手术的患者可能会发生肋间神经损伤。
2019 年,澳洲大约进行了 47,083 例扁桃体切除术。舌咽神经位于扁桃体底,因此在扁桃体切除术期间特别容易受伤。
在手术期间使用神经监测系统可以降低任何手术过程中神经损伤的风险。
因此,各种外科手术的增加增加了神经损伤的风险,导致对神经监测系统的需求增加,从而推动了未来几年的整体神经监测系统市场。
然而,频繁的产品召回和设备的高成本可能会限制神经监测系统市场的成长。
神经监测系统细分市场分析
在神经监测系统市场的技术领域,肌电图 (EMG) 类别预计将占据最大份额。
肌电图用于分析、评估和记录骨骼肌及其相关运动神经元的电活动。帮助准确有效地诊断肌肉病变、神经病变以及影响肌肉和神经之间连接的疾病。
肌电图还可以在腰椎减压或腰间融合期间从任何途径监测神经。前路(ALIF)、后路(PLIF/TLIF)、侧路(XLIF)、全腰椎间盘置换术、马尾手术、前路颈椎间盘切除融合术(ACDF)、全颈椎间盘置换术、后路颈椎融合术(PCF)、脊椎肿瘤切除术、脊椎侧弯手术及胸椎椎体成形术。
此外,预计产品发布和批准的增加也将增加预测期内对肌电图的需求。例如,2022 年 11 月,Xavant Technology 宣布获得 FDA 批准,将其 STIMPOD 系列定量 NMT 监测仪的感测器技术扩展到包括肌电图 (EMG)。先前,Xavant 的定量神经肌肉监测 (NMT) 监视器仅具有加速肌电图 (AMG) 感测器。
已开发国家对基于肌电图的外科手术的优惠政府报销政策以及肌电图神经监测在术中应用中的大量使用预计将推动神经监测系统市场的发展。
北美预计将主导整个神经监测系统市场
预计在预测期内,北美将主导整个神经监测系统市场。这种主导地位是由于对神经监测系统先进技术的需求不断增长、外科手术数量不断增加以及该地区主要市场参与者的存在。
该报告提供了全球神经监测系统市场的研究和分析,包括市场规模和预测、驱动因素和挑战以及公司和产品概况。
Nerve Monitoring Systems Market By Product (Nerve Monitors, Nerve Stimulation Electrodes, and Probes), Technology (Electromyography (EMG), Electroencephalography (EEG), Electrocorticography (ECOG), and Evoked Potential (EP)), Application (Neurosurgery, ENT Surgery, Cardiovascular, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to rise in nerve-related disorders and rising use of nerve monitoring systems in trauma cases
The global nerve monitoring systems market was valued at USD 1.28 billion in 2023, growing at a CAGR of 4.17% during the forecast period from 2024 to 2030, to reach USD 1.63 billion by 2030. The demand for nerve monitoring systems is primarily motivated by the rise in nerve-related disorder patient population, easy availability of medical reimbursement for these procedures, increasing demand for advanced products, and the strong presence of device manufacturers in the market.
Nerve Monitoring Systems Market Dynamics:
One of the key factors influencing the growth of the nerve monitoring systems market is the increasing burden of surgical numbers across the globe.
As per the OECD, nearly 9,451 coronary artery bypass graft procedures were performed in the United Kingdom in 2020. Also, approximately 38,859 coronary artery bypass graft procedures were performed in Germany in the same year. The same source stated that 26,355 transluminal coronary angioplasty procedures were performed in Switzerland, in 2020. In the same year, 53,993 transluminal coronary angioplasty procedures were performed in Spain.
Nerve injuries associated with angiography and endovascular interventions are rare and usually transient but may result in significant functional impairment and are largely avoidable. Intercostal nerve damage may occur in three-quarters of all patients undergoing coronary artery bypass graft-internal thoracic artery surgery.
In addition, nearly, 47,083 tonsillectomy procedures were performed in 2019, in Australia. The glossopharyngeal nerve is particularly prone to injury during tonsillectomy because of its position in the tonsillar bed.
The risk of damage to the nerve during any surgical procedure can be reduced if a nerve monitor system is used during the surgery.
Thus, the increasing number of various surgical procedures can increase the risk of nerve damage, leading to an increased demand for nerve monitoring systems, thereby propelling the overall market for nerve monitoring systems in the upcoming years.
However, frequent product recalls and the high cost of the devices may act as a restraint in the growth of the nerve monitoring systems market.
Nerve Monitoring Systems Market Segment Analysis:
Nerve Monitoring Systems by Product (Nerve Monitors, Nerve Stimulation Electrodes and Probes), Technology (Electromyography (EMG), Electroencephalography (EEG), Electrocorticography (ECOG), and Evoked Potential (EP)), Application (Neurosurgery, ENT Surgery, Cardiovascular, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the technology segment of the nerve monitoring systems market, the electromyography (EMG) category is expected to hold the largest share in the nerve monitoring systems market.
EMG is used for the analysis, evaluation, and recording of the electrical activity of skeletal muscles and motor nerve cells associated with them. It assists in the accurate and effective diagnosis of muscle disorders, nerve disorders, and disorders affecting the connection between the muscles and nerves.
Along with this, the EMG can be used to monitor nerve during lumbar decompression surgery, during lumbar interbody fusion surgery from any approach: anterior (ALIF), posterior (PLIF, TLIF), lateral (XLIF®), lumbar total disc replacement procedure, cauda equina surgery, anterior cervical discectomy and fusion (ACDF), cervical total disc replacement, posterior cervical fusion (PCF), spinal cord tumor resections, scoliosis surgery, and thoracic vertebroplasty procedures.
Further, increasing product launches and approvals will also increase the demand for electromyography during the forecast period. For instance, in November 2022, Xavant Technology announced that the FDA has approved the expansion of the sensor technology in its STIMPOD range of Quantitative NMT Monitors to include electromyography (EMG). To date, Xavant's range of Quantitative Neuromuscular Monitoring (NMT) monitors have been equipped with acceleromyography (AMG) sensors only.
Favorable reimbursement policies by the government for EMG-assisted surgical procedures in developed countries and the significant use of EMG nerve monitoring for intraoperative applications will boost the nerve monitoring systems market.
North America is expected to dominate the overall Nerve Monitoring Systems Market:
North America is expected to dominate the overall Nerve Monitoring Systems market during the forecast period. This domination is due to the growing demand for advanced technologies in nerve monitoring systems, and the growing number of surgical procedures, coupled with the presence of major market players in the region.
As per the Lifespan Health System Organization 2022, there are about 5,00,000 open heart surgeries that are performed every year in the United States. Ulnar neuropathy is a documented complication after many operations, but especially after open-heart operations. It is believed that the nerve dysfunction may be due to improper positioning of the forearms and hands during or following the operation. This complication can be avoided if nerve monitoring systems are used while the surgical procedure to monitor the nerve activity and to assess the nerve which is at risk.
The presence of favorable regulatory authority in the country will also increase the overall market as this will result in a higher rate of approval of medical devices. For instance, in October 2020, Medtronic secured Food and Drug Administration (FDA) 510(k) clearance of the NIM Vital nerve monitoring system, which enables doctors to identify, confirm, and monitor nerve function to help cut down the risk of nerve damage during head and neck surgery.
Thus, all the above-mentioned factors will lead to an increase in the United States nerve monitoring systems market growth during the forecasting period of 2024-2030.
Key Nerve Monitoring Systems Market Companies:
Some of the key market companies operating in the Nerve Monitoring Systems market include NuVasive®, Inc., Medtronic PLC, Nihon Kohden Corporation, Natus Medical Incorporated, Innopsys Inc., Neurovision Medical Products, NeuroWave Systems Inc., Cadwell Industries, Inc., Dr. Langer Medical GmbH, Inomed Medizintechnik GmbH, Symmetry Surgical, Checkpoint Surgical Inc., Neurosign®, EMS Handels Gesellschaft mbH, Halyard Health, and others.
Recent Developmental Activities in the Nerve Monitoring Systems Market:
In May 2021, Neurosign announced the US launch of its V4 system for monitoring cranial nerves and spinal nerve roots during surgeries. US Food & Drug Administration (FDA) cleared the V4 4-channel and 8-channel nerve monitoring systems in March.
In October 2020, Medtronic secured FDA 510(k) clearance of the NIM Vital nerve monitoring system, which enables doctors to identify, confirm, and monitor nerve function to help cut down the risk of nerve damage during head and neck surgery.
In February 2019 Alphatec Holdings, Inc. announced that it has received 510(k) clearance from the FDA for its automated SafeOp neuromonitoring system for use in real-time intraoperative nerve location and health assessment.
Key Takeaways from the Nerve Monitoring Systems Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Nerve Monitoring Systems market.
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the Global Nerve Monitoring Systems Market.
Various opportunities are available for the other competitor in the Nerve Monitoring Systems Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Nerve Monitoring Systems market growth in the coming future?
Target Audience who can be benefited from this Nerve Monitoring Systems Market Report Study
Nerve Monitoring Systems providers
Research organizations and consulting companies
Nerve Monitoring Systems related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in Nerve Monitoring Systems
Various end-users want to know more about the Nerve Monitoring Systems Market and the latest technological developments in the Nerve Monitoring Systems market.
Frequently asked questions for Nerve Monitoring Systems Market:
What is a Nerve Monitoring System?
A Nerve Monitoring System is a medical tool used in operations and procedures to check the health and efficiency of nerves. It is mostly used in procedures that put patients at risk for nerve damage, including spinal, thyroid, facial nerve, and several head and neck surgeries.
What is the market for Global Nerve Monitoring System?
The Global Nerve Monitoring System Market was valued at USD 1.28 billion in 2021, growing at a CAGR of 4.71% during the forecast period from 2024 to 2030, to reach USD 1.63 billion by 2030.
Who are the leading companies in the Nerve Monitoring System Market Landscape?
Some of the Key Nerve Monitoring System companies in the Market include Medtronic, Nihon Kohden Corporation, NuVasive, Inc., Natus Medical Incorporated, Inomed Medizintechnik GmbH, NerveVision, Axon Systems, Sentio LLC, Nervomatrix, Nerve Stim SPA, Bovie Medical Corporation, Neurovision Medical Products, Magstim Company Limited, Neurosign Surgical, Checkpoint Surgical, Inc., EMS Handels Gesellschaft mbH, ORIMtec GmbH, Xavant Technology (Pty) Ltd., NeuroWave Systems Inc., Scopis GmbH, and many others.
What are the key strengths of the Nerve Monitoring System Market Report?
Key strengths of Nerve Monitoring System Market Report are 05 Years Forecast, Global Coverage, Competitive Landscape, Market Size, Market Segmentation, Market Company Profiles, Market PORTER's Five Forces Analysis, and Market Share.
Which regions have the highest share in the Nerve Monitoring System Market?
North America is expected to dominate the overall market during the forecast period, 2024 to 2030. This domination is due to the growing demand for advanced technologies in the Nerve Monitoring System. The increased diseases in the region are driving the growth of the Nerve Monitoring System market.